TP53 and lung carcinoma: Since p53 can function as an inhibitor of inflammation [19], mutant p53 proteins may be involved in deregulated inflammation contributing to the pathogenesis of lung cancer and other cancers and then serum p53Abs may be early markers of tumor development in people at high risk of cancer, such as patients with impaired lung function.